CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-14 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-06-14 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +2,379 | $29.42 | $70K | 2,379 |
| 2021-06-14 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-06-14 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +1,529 | $29.42 | $45K | 1,529 |
| 2021-06-14 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-06-14 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +15,295 | 15,295 | ||
| 2021-06-14 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-06-14 | Bjork Elisabeth Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-06-14 | Bjork Elisabeth Director | Grant or award · Stock Option (Right to Buy) | +1,699 | $29.42 | $50K | 1,699 |
| 2021-06-14 | Yalamanchi Naveen Director | Grant or award · Stock Option (Right to Buy) | +12,236 | 12,236 | ||
| 2021-05-11 | RTW INVESTMENTS, LP Director | Sale | −725,000 | $40.03 | $29.0M | 15,460,119 |
| 2021-05-11 | RTW INVESTMENTS, LP Director | Other acquisition · Equity Swap (Obligation to Buy) 1) | +1 | 1,000,000 | ||
| 2021-04-01 | Shah Gaurav CEO | Shares withheld for taxes | −5,919 | $45.21 | $268K | 511,986 |
| 2021-04-01 | Shah Gaurav CEO | Shares withheld for taxes | −8,872 | $46.45 | $412K | 503,114 |
| 2021-04-01 | Shah Gaurav CEO | Shares withheld for taxes | −7,475 | $47.21 | $353K | 495,639 |
| 2021-03-31 | Shah Gaurav CEO | Shares withheld for taxes | −7,493 | $45.94 | $344K | 517,905 |
| 2021-03-31 | Shah Gaurav CEO | Exercise or conversion | +75,880 | $1.69 | $128K | 612,751 |
| 2021-03-31 | Shah Gaurav CEO | Shares withheld for taxes | −3,000 | $45.59 | $137K | 609,751 |
| 2021-03-31 | Shah Gaurav CEO | Shares withheld for taxes | −61,350 | $44.24 | $2.7M | 548,401 |
| 2021-03-31 | Shah Gaurav CEO | Shares withheld for taxes | −23,003 | $45.06 | $1.0M | 525,398 |
Page 22 of 27 · 538 trades